Cargando…

277. Comparison of Oral Beta-Lactams and Fluoroquinolones for Step-Down in Uncomplicated Enterobacterales Blood Stream Infections

BACKGROUND: Bloodstream infections (BSI) with Enterobacterales (formerly Enterobacteriaceae) group organisms are a frequently encountered complication, often stemming from urinary tract infections. Recent studies have demonstrated similar outcomes among patients transitioned to oral antibiotics comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ngo, Nichol, Sielatchom-Noubissie, Lionel, Molina, Kyle, Johnson, Tanner M, Huang, Misha, Hojat, Leila S, Kiser, Ty, miller, matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777811/ http://dx.doi.org/10.1093/ofid/ofaa439.321

Ejemplares similares

Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source
por: Sutton, Jesse D., et al.
Publicado: (2020)

Comparative-Effectiveness of Oral Beta-Lactams and Fluoroquinolones for Stepdown Therapy in Patients with Enterobacterales Bloodstream Infections: A Retrospective Cohort Study
por: Bjork, Lauren, et al.
Publicado: (2023)

539. Impact of a Rapid Diagnostic Assay for the Detection of Bacterial and Viral Agents on Antimicrobial use in Critically Ill Patients with Pneumonia
por: Sielatchom Noubissie, Lionel K, et al.
Publicado: (2022)

1822. Clinical Outcomes Associated with Oral Beta-Lactam Therapy versus Oral Fluoroquinolones/TMP-SMX for Uncomplicated Gram-Negative Bacteremia
por: Kaur, Satwinder S, et al.
Publicado: (2022)

Impact of Education on Fluoroquinolone Use in Uncomplicated Cystitis
por: Ferren, Ryan, et al.
Publicado: (2017)

Beta-Lactam-Resistant Enterobacterales Isolated from Landfill Leachates
por: Mondragón-Quiguanas, Alejandra, et al.
Publicado: (2022)

Oral Fluoroquinolone or Trimethoprim-Sulfamethoxazole vs ß-Lactams as Step-Down Therapy for Enterobacteriaceae Bacteremia: Systematic Review and Meta-analysis
por: Punjabi, Chitra, et al.
Publicado: (2019)

1022. Is it Time to Re-Evaluate Oral Β-Lactam Antibiotics for Step-Down Therapy of Uncomplicated Gram-Negative Bacteremia?
por: McAlister, Michael, et al.
Publicado: (2019)

Association of Carbapenemase-Producing Enterobacterales Detected in Stream and Clinical Samples
por: Sung, Gyung-Hye, et al.
Publicado: (2022)

271. Clinical Outcomes Treating Gram-Negative Bacteremia with Oral Beta-Lactams vs. Trimethoprim-Sulfamethoxazole or Fluoroquinolone Step-Down Therapy
por: Sinclair, Emily, et al.
Publicado: (2020)

Impact of Fluoroquinolone Susceptibility Suppression on Discharge Prescribing for Acute Uncomplicated Cystitis
por: Hayden, Dillon A, et al.
Publicado: (2023)

Breaking down the barriers to health equity
por: Hojat, Leila S.
Publicado: (2022)

294. Interim Analysis of an Evidence-Based Bundle Intervention for Uncomplicated Enterobacterales Bacteremia
por: Stallsmith, Jena, et al.
Publicado: (2020)

Prevalence and Abundance of Beta-Lactam Resistance Genes in Hospital Wastewater and Enterobacterales Wastewater Isolates
por: Santosaningsih, Dewi, et al.
Publicado: (2023)

1459. Oral Cephalosporins vs. Fluoroquinolones for the Empiric Treatment of Acute Uncomplicated Pyelonephritis
por: Lin, Kevin, et al.
Publicado: (2019)

70. Impact of Fluoroquinolone Susceptibility Suppression on Discharge Prescribing for Acute Uncomplicated Cystitis
por: Hayden, Dillon, et al.
Publicado: (2020)

Broad-Spectrum Cephalosporin-Resistant and/or Fluoroquinolone-Resistant Enterobacterales Associated with Canine and Feline Urogenital Infections
por: Loncaric, Igor, et al.
Publicado: (2020)

Characterization of cephalosporin and fluoroquinolone resistant Enterobacterales from Irish farm waste by whole genome sequencing
por: Prendergast, Deirdre M., et al.
Publicado: (2023)

The role of the plasmid-mediated fluoroquinolone resistance genes as resistance mechanisms in pediatric infections due to Enterobacterales
por: Logan, Latania K., et al.
Publicado: (2023)

Health Tract, No. 277: The Tomatoe
Publicado: (1867)

278. Comparison of Oral Cephalexin Versus Oral Levofloxacin for Treatment of Uncomplicated Enterobacterales Bacteremia
por: Leung, Thomas H, et al.
Publicado: (2020)

1072. Streamlining to Oral β-Lactam vs. Fluoroquinolone as Definitive Therapy for Enterobacteriaceae Bacteremia
por: Fong, Karen, et al.
Publicado: (2018)

Effect of the Short-Term Use of Fluoroquinolone and β-Lactam Antibiotics on Mouse Gut Microbiota
por: Gu, Si-Lan, et al.
Publicado: (2020)

A Review of the Resistance Mechanisms for β-Lactams, Macrolides and Fluoroquinolones among Streptococcus pneumoniae
por: Zahari, Nurul Izzaty Najwa, et al.
Publicado: (2023)

Monitoring of Non-β-Lactam Antibiotic Resistance-Associated Genes in ESBL Producing Enterobacterales Isolates
por: Shinu, Pottathil, et al.
Publicado: (2020)

1115. Use of a Fluoroquinolone (FQ) vs. a Non-Fluoroquinolone (Non-FQ)-Based Antibiotic Regimen in the Treatment of Acute, Uncomplicated Diverticulitis
por: Mourani, Jessyca, et al.
Publicado: (2018)

Fluoroquinolone and beta-lactam antimicrobials induce different transcriptome profiles in Salmonella enterica persister cells
por: Mattiello, S. P., et al.
Publicado: (2023)

216. Step-down Therapy With Oral Fluoroquinolones vs. Oral β-Lactams for Hospitalized Adult Patients with Community-Acquired Pneumonia: A Multi-Hospital Cohort Study
por: Petty, Lindsay, et al.
Publicado: (2018)

210. Step-down from IV to oral therapy in patients with bacteremia due to Enterobacteriaceae: fluoroquinolones (FQ) vs. ß-lactams (BL) or trimethoprim-sulfamethoxazole (TMP-SMX)
por: Meng, Lina, et al.
Publicado: (2019)

The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia
por: Mortensen, Eric M, et al.
Publicado: (2006)

Effects of β-Lactam Antibiotics and Fluoroquinolones on Human Gut Microbiota in Relation to Clostridium difficile Associated Diarrhea
por: Knecht, Henrik, et al.
Publicado: (2014)

165. Comparative Effectiveness of Oral Fluoroquinolones vs. β-Lactams for the Treatment of Patients with Enterobacteriaceae Bloodstream Infections
por: Bjork, Lauren, et al.
Publicado: (2019)

Exploring antimicrobial resistance to beta-lactams, aminoglycosides and fluoroquinolones in E. coli and K. pneumoniae using proteogenomics
por: Foudraine, Dimard E., et al.
Publicado: (2021)

Beta-Lactam vs. Fluoroquinolone Monotherapy for Pseudomonas aeruginosa Infection: A Systematic Review and Meta-Analysis
por: Reid, Eric, et al.
Publicado: (2021)

Enhancing activity of β-lactam and fluoroquinolones antibiotics by artemisinin and its derivatives against MDR Escherichia coli
por: Ul Haq, Shahbaz, et al.
Publicado: (2022)

In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant Enterobacterales
por: Peters, Byron K., et al.
Publicado: (2023)

201909-277 OpenDays ME-31
por: Ordan, Julien Marius, et al.
Publicado: (2019)

1145. The Role of the Plasmid-Mediated Fluoroquinolone-Resistance (PMFQR) Genes As Resistance Mechanisms in Pediatric Infections due to Enterobacterales (Ent)
por: Pitstick, Claire E, et al.
Publicado: (2021)

Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study
por: Ernst, Pierre, et al.
Publicado: (2019)

Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams
por: Bolhuis, Mathieu S., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_35c8f6hhn11q9n90l4hvqf2cqh